Complement-induced impairment of the innate immune system during sepsis

Current Allergy and Asthma Reports

Volumn 4, Issue 5, 2004, Pages 359-364

  Albrecht, Eric A ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; PLASMA PROTEIN;

BACTERIAL INFECTION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CYTOLYSIS; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNITY; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; MEMBRANE STRUCTURE; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; REVIEW; SEPSIS; SYSTEMIC DISEASE;

EID: 4544241629     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-004-0084-3     Document Type: Review

References (50)

1. Wagner JG, Roth RA: Neutrophil migration during endotoxemia. J Leukoc Biol 1999, 66:10-24.
2. Barrington R, Zhang M, Fischer M, et al.: The role of complement in inflammation and adaptive immunity. Immunol Rev 2001, 180:5-15.
3. Ward P: The dark side of C5a in sepsis. Nature Rev Immunol 2004, 4:133-142.
4. Riedemann N, Guo R, Ward P: Novel strategies for the treatment of sepsis. Nature Med 2003, 9:517-524.
5. Boackle S: Complement and autoimmunity. Biomed Pharmacother 2003, 57:269-273.
6. Nakano Y, Morita S, Kawamoto A, et al.: Elevated complement C3a in plasma from patients with severe acute asthma. J Allerg Clin Immunol 2003, 112:525-530.
7. Groeneveld A, Tacx A, Bossink A, et al.: Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection. Clin Immunol 2003, 106:106-115.
8. Marc M, Korosec P, Kosnik M, et al.: Complement factors C3a, C4a, and C5a in chronic obstructive pulmonary disease and asthma. Am J Respir Cell Mol Biol 2004, In press.
9. Weisman H, Bartow T, Leppo M: Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990, 249:149-151.
10. Basta M, Goor F, Luccioli S, et al.: F(ab)′2-mediated neutralization of C3a and C5a anapylatoxins: a novel effector function of immunoglobulins. Nature Med 2003, 9:431-438.
11. Taube C, Rha Y, Takeda K, et al.: Inhibition of complement activation decreases airway inflammation and hyperresponsiveness. Am J Respir Crit Care Med 2003, 168:1333-1341.
12. Czermak B, Sarma V, Pierson C, et al.: Protective effects of C5a blockade in sepsis. Nature Med 1999, 5:788-792.
13. Ahmed NA, McGill S, Yee J, et al.: Mechanisms for the diminished neutrophil exudation to secondary inflammatory sites in infected patients with a systemic inflammatory response (sepsis). Crit Care Med 1999, 27:2459-2468.
14. Victor VM, Rubio D, de la Fuente M: Comparative study of several lymphocyte functions in two strains of mice with different models of endotoxic shock. Physiol Res 2002, 51:291-298.
15. Huber-Lang H, Sarma V, Lu K, et al.: Role of C5a in multiorgan failure during sepsis. J Immunol 2001, 166:1193-1199.
16. Goya T, Morisaki T, Torisu M: Immunologic assessment of host defense impairment in patients with septic multiple organ failure: relationship between complement activation and changes in neutrophil function. Surgery 1994, 115:145-155.
17. Etheredge E, Spitzer J: Chronic endotoxemia reversibly alters respiratory burst activity of circulating neutrophils, J Surg Res 1993, 55:261-268.
18. Kajdacsy-Balla A, Doi F, Lerner M, et al.: Dose-response effect of in vivo administration of endotoxin on polymorphonuclear leukocytes oxidative burst. Shock 1996, 5:357-361.
19. Huber-Lang M, Younkin E, Sarma V, et al.: Complement-induced impairment of innate immunity during sepsis. J Immunol 2002, 169:3223-3231.
20. Sprong T, Brandtzaeg P, Fung M, et al.: Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis. Blood 2003, 102:3702-3710.
21. Simms H, D'Amico, Burchard R: Untreated intrabdominal sepsis: lack of synergism between polymorphonuclear leukocytes (PMN) complement receptors CR1/CR2 and IgG receptor FcRIII. J Trauma 1990, 30:1027-1031.
22. Fierro I, Barja-Fidalgo C, Cunha F, et al.: The involvement of nitric oxide in the anti-Candida albicans activity of rat neutrophils. Immunology 1996, 89:295-300.
23. Martins P, Kallas, Esper G, et al.: Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock. Shock 2003, 20:208-212.
24. Shih HC, Su CH, Lee CH: Superoxide production of neutrophils after severe injury: impact of subsequent surgery and sepsis. Am J Emerg Med 1999, 17:15-18.
25. Lanser M, Brown G, Mora R, et al.: Trama serum suppresses superoxide production by normal neutrophils. Arch Surg 1986, 121:157-161.
26. Zimmerman J, Millard J, Farrin-Rusk C: Septic plasma suppresses superoxide anion synthesis by normal homologous polymorphonuclear leukocytes. Crit Care Med 1989, 17:1241-1249.
27. Mollnes T, Brekke O, Fung M, et al.: Essential role of C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 2002, 100:1869-1877.
28. Kharazmi A, Anderson L, Baek L, et al.: Endotoxemia and enhanced generation of oxygen radicals by neutrophils from patients undergoing cardiopulmonary bypass. J Thorac Cardiac Surg 1989, 98:381-385.
29. Cerasoli F, McKenna P, Rosalia D, et al.: Superoxide anion release from blood and bone marrow neutrophils is altered by endotoxemia. Circ Res 1990, 67:154-165.
30. Chenoweth D, Hugli T: Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A 1978, 75:3943-3947.
31. Gerard N, Hodges M, Drazen J, et al.: Characterization of a receptor of C5a anaphylatoxin on eosinophils. J Biol Chem 1989, 264:1760-1766.
32. Hwang J, Fraser I, Choi S, et al.: Analysis of C5a-mediated chemotaxis by lentiviral delivery of small interfering RNA. Proc Natl Acad Sci 2004, 100:488-493.
33. Nataf S, Stahel PF, Davoust N, et al.: Complement anaphylatoxin receptors on neurons: new tricks for old receptors? Trends Neurosci 1999, 22:397-402.
34. Barnum S, Ames R, Maycox P, et al.: Expression of the complement C3a and C5a receptors after permanent focal ischemia: an alternative interpretation. Gila 2002, 38:169-173.
35. Riedemann N, Guo R, Neff T, et al.: Increased C5a receptor expression in sepsis. J Clin Invest 2002, 110:101-108.
36. Huber-Lang M, Riedeman N, Sarma V, et al.: Protection of innate immunity by C5aR antagonist in septic mice. FASEB 12002, 16:1567-1574.
37. Guo R, Riedemann N, Bernacki K, et al.: Neutrophil C5a receptor and the outcome in a rat model of sepsis. FASEB J 2003, 17:1889-1891.
38. Furebring M, Hakansson L, Venge P, et al.: Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis. Crit Care 2002, 6:363-370.
39. Drouin SM, Kildspard J, Haviland J, et al.: Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol 2001, 166:2025-2032.
40. Harkin D, Romaschin A, Taylor S, et al.: Complement C5a receptor antagonist attenuates multiple organ injury in a model of ruptured abdominal aortic aneurysm. J Vasc Surg 2004, 39:196-206.
41. Grant E, Picarella D, Burwell T, et al.: Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J Exp Med 2002, 196:1461-1471.
42. Hattori R, Hamilton K, McEver R, et al.: Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 1989, 264:9053-9060.
43. Kilgore K, Shen J, Miller B, et al.: Enhancement by the complement membrane attack complex of tumor necrosis factor-α -induced endothelial cell expression of E selectin and ICAM-1. J Immunol 1995, 155:1434-1441.
44. Topham P, Haydar S, Kuphal R, et al.: Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions. Kidney Int 1999, 55:1763-1775.
45. Takano T, Cybulsky A: Complement C5b-9 mediated arachidonic acid metabolism in glomerular epithelial cells. Am J Pathol 2000, 156:2091-2101.
46. Mead R, Singhrao S, Neal J, et al.: The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J Immunol 2002, 168:458-465.
47. Gasque P, Dean Y, McGreal E, et al.: Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 2000, 49:171-186.
48. Graham R, Leslie Q, Nielsen C: The classical and alternative pathways of complement activation play distinct roles in spontaneous C3 fragment deposition and membrane attack complex (MAC) formation on human B lymphocytes. Immunology 2004, 111:86-90.
49. Niculescu F, Soane L, Badea T, et al.: Tyrosine phosphorylation and activation of Janus kinase 1 and stat 3 by sublytic C5b-9 complement complex in aortic endothelial cells. Immunopharmacology 1999, 42:187-193.
50. Badea T, Jae-Hyun P, Soane L, et al.: Sublytic terminal complement attack induces c-fos transcriptional activation in myotubes. J Neuroimmunol 2003, 142:58-66.